JP Morgan Chase’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Buy
7,415
+313
+4% +$13.5K ﹤0.01% 5281
2025
Q4
$285K Buy
7,102
+641
+10% +$25.4K ﹤0.01% 5345
2025
Q3
$255K Buy
6,461
+331
+5% +$12.2K ﹤0.01% 5385
2025
Q2
$228K Buy
6,130
+286
+5% +$9.7K ﹤0.01% 5171
2025
Q1
$196K Buy
+5,844
New +$206K ﹤0.01% 5249

Other funds holding CPAI

JP Morgan Chase's CPAI Position: Q1 2026 in Review

JP Morgan Chase increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 4.4% in Q1 2026, buying an estimated $13.5K and bringing the position to 7,415 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #5281.

JP Morgan Chase first reported a position in CPAI in Q1 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold CPAI as of Q1 2026.

  • JP Morgan Chase held 7,415 shares of Counterpoint Quantitative Equity ETF worth $300K as of Q1 2026.
  • JP Morgan Chase bought 313 Counterpoint Quantitative Equity ETF shares in Q1 2026, an estimated $13.5K.
  • Counterpoint Quantitative Equity ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5281 holding.
  • JP Morgan Chase first reported a position in Counterpoint Quantitative Equity ETF in Q1 2025 and has held it in 5 quarters since.
  • 33 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.